Examining progression-free survival in first- and second-line treatment for BRAF-mutant metastatic colorectal cancer (CRC)

Lee, BelindaAnton, AngelynLee, MargaretWong, RachelParente, PhillipShapiro, Jeremy D.Yip, DesmondSteel, Simone AnneNott, L.Stefanou, GregoryIddawela, MaheshGibbs, PeterTran, BenStephen A. Cannistra2020-08-182020-08-18January 190732-183X0732-183Xhttp://hdl.handle.net/1885/207837Volume: 35, Issue: Supplement 4, Abstract: 728application/pdfen-AU© 2017 by American Society of Clinical OncologyExamining progression-free survival in first- and second-line treatment for BRAF-mutant metastatic colorectal cancer (CRC)201710.1200/JCO.2017.35.4_suppl.7282022-08-07